Drug Trial Radar · NCT05385978
A Study of Distal Jejunal-release Dextrose in Obese Participants
Last checked: Nov 19, 2026Latest source record: Oct 16, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Nov 1, 2022
Primary completion
Nov 11, 2024
Study completion Nov 11, 2024
Sponsor
- Lead sponsor
- Aphaia Pharma US LLCIndustry
- Sponsor type
- Industry
- First posted
- May 23, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of the study is to evaluate the efficacy and safety of APHD-012 (distal jejunal-release dextrose \[Aphaia technology, AT\]) in obese participants.
Conditions
- Obese
Interventions
APHD-012Drug
Distal jejunal-release dextrose beads (Aphaia technology, AT)
APHD-012PDrug
Distal jejunal-release placebo beads
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes from Baseline in Percent Weight Change Compared with PlaceboTime frame: At Baseline and at each visit until Day 180 for Cohort 2 and Day 360 for Cohort 1
Locations
9 sites in 3 countries. Site status is shown where the registry gives one.
LTD "Israeli-Georgian Medical Research Clinic Healthycore"
Tbilisi, Georgia
LTD "Acad. G. Chapidze Emergency Cardiology Center"
Tbilisi, Georgia
LTD "Diacor"
Tbilisi, Georgia
LTD "National Institute of Endocrinology"
Tbilisi, Georgia
LTD "Tbilisi Heart Center"
Tbilisi, Georgia
Universitätsklinikum Schleswig-Holstein
Lübeck, Germany
Universitätsklinikum Ruppin-Brandenburg
Neuruppin, Germany
GCM Medilcal Group
San Juan, Puerto Rico
FDI Clinical Research
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.